Streetbeat News

Marketing

TSLA

The weekend's top stories included a public opinion poll showing dissatisfaction with both Joe Biden and Donald Trump, Elon Musk's reaction to the sentencing of ex-FBI official Charles McGonigal, debunked claims about Trump and a lemonade incident, a rally in Tesla Inc. (NASDAQ:TSLA) stock that rendered Senator Tommy Tuberville's put options worthless, and a prediction of a potential breakout for the cryptocurrency Shiba Inu.

Portfolio Pulse from Benzinga Neuro

December 18, 2023 | 1:03 pm

ACHL

Achilles Therapeutics has announced the publication of a 'Comment' in Nature Cancer discussing strategies for better prediction of neoantigen immunogenicity, which is crucial for the development of cancer immunotherapies.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 12:22 pm

AAPL

Apple Inc. has introduced 'Contingent pricing' for App Store developers, allowing them to offer subscription discounts to users who subscribe to multiple services. This feature enables developers to collaborate and provide discounts to users who are subscribed to another service, potentially by a different developer. The initiative aims to attract and retain subscribers, offering a win-win situation for users, developers, and Apple. In 2022, developers generated $1.1 trillion in sales through the App Store, with 90% of the revenue going to developers.

Portfolio Pulse from Rounak Jain

December 18, 2023 | 9:56 am

HIMX

Himax Technologies, Inc. (NASDAQ:HIMX) is set to debut its HX83132 series in-cell TDDI for LCD notebooks and HX85200 series on-cell touch controller for premium AMOLED notebooks at CES 2024. The event, which is the largest consumer electronics show, will take place in Las Vegas from January 9 to 12, 2024.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 9:04 am

BB

BlackBerry Limited will be presenting its BlackBerry IVY connected vehicle data platform at CES 2024. The platform allows developers to create automotive services rapidly by utilizing in-vehicle AI and a developer-friendly environment. The diversity of solutions on the BlackBerry IVY platform offers automakers new ways to differentiate and monetize connected cars.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 8:04 am

XPEV

Xpeng Inc. (NYSE:XPEV) has announced a limited-time discount of RMB 10,000 ($1,400) on its G6 SUV starting Dec. 18, following a previous price cut on the P7i sedan. The G6's price reduction and a 24-term zero-interest loan option aim to boost sales amid a plateau in growth and increasing competition in China's EV market. Despite a downturn in the Hong Kong stock market and divestment concerns, Xpeng reported a 25% year-on-year sales growth in Q3 FY23 and a record delivery of over 20,000 vehicles in November.

Portfolio Pulse from Benzinga Neuro

December 18, 2023 | 7:41 am

MBGAF

TSLA

A Mercedes-Benz dealership in Texas distributed printed copies of a CNN article about a Tesla Autopilot recall to its customers. The recall, announced by the NHTSA, led to Tesla issuing a software update to address the issues. Mercedes-Benz's action highlights the competition with Tesla and its active pursuit of EV market share. Tesla's OTA update solution for the recall has been criticized by some as misleading. Despite this, Tesla remains a strong investment in the EV industry, according to Gary Black of Future Fund.

Portfolio Pulse from Benzinga Neuro

December 18, 2023 | 6:25 am

DOGEUSD

FLOKIUSD

SHIBUSD

Crypto analysts are predicting a surge for meme coins, particularly Shiba Inu (CRYPTO: SHIB) and Floki (CRYPTO: FLOKI). Crypto Tony highlighted SHIB's momentum and anticipates a 'supreme pump' for FLOKI. Another analyst, MacroCRG, considers FLOKI a 'blue-chip' meme coin with intrinsic value. FLOKI is also launching an aggressive marketing campaign in Hong Kong. Additionally, Ali Martinez suggests a potential breakout for SHIB if it maintains a support level.

Portfolio Pulse from Mehab Qureshi

December 18, 2023 | 3:35 am

AMZN

Ivanka Trump praised Jeff Bezos' 'Day One' philosophy on X, drawing parallels with Alan Watts' teachings. Bezos discussed various topics on a podcast with Lex Fridman, including his leadership style, Amazon's journey, and his aerospace company Blue Origin. The podcast has over 1.5 million views on YouTube.

Portfolio Pulse from Ananya Gairola

December 18, 2023 | 1:56 am

ARQT

The FDA has approved Arcutis Biotherapeutics' ZORYVE topical foam for treating seborrheic dermatitis in individuals aged 9 and older. ZORYVE is the first drug with a new mechanism of action for this condition in over 20 years, offering rapid disease clearance and significant itch reduction. The product is expected to be commercially available by the end of January 2024. Arcutis will host a conference call on December 18 to discuss the approval. The approval is based on positive results from Phase 2 and Phase 3 trials, with ZORYVE showing high efficacy and safety.

Portfolio Pulse from Happy Mohamed

December 16, 2023 | 11:41 pm